Continuity of supply
We hold stock against agreed forecasts rather than ordering reactively, so a treatment protocol is not interrupted by a shipment that did not arrive.
Partner with us
Reliable specialty-medicine supply for the places patients are treated.
For hospitals, oncology treatment centres, dialysis and transplant units, and institutional procurement and pharmacy teams across Nepal.
Direction three · Institutional
Direct supply for hospitals and treatment centres.
Specialty medicines fail patients in two ways: they are unavailable, or they arrive having lost their integrity in transit. Institutional supply is where both risks are decided.
We supply registered medicines to hospitals, oncology treatment centres, dialysis and transplant units, and institutional pharmacy departments through valid purchase orders or tenders. For an unregistered medicine required in an exceptional clinical situation, we can help the institution understand the applicable DDA special-permission process; supply is never implied before written approval.
What we offer institutions
Supply you can plan around.
Documented handling
Cold-chain products are transported under monitored conditions with batch-level records maintained from import through to delivery at your pharmacy.
Tender participation
We respond to government and hospital procurement tenders across our therapeutic areas, with the regulatory documentation prepared in advance.
Medical information
Product and prescribing information routed to your clinicians through our regulatory function and the marketing authorisation holder.
Pharmacovigilance support
A defined route for reporting adverse events and product complaints, handled to Nepali requirements.
Access support
Where a therapy is unaffordable for a patient, we will work with you on what options exist rather than treating price as fixed.
Ways to engage
Three routes.
| Route | How it works | Suits |
|---|---|---|
| Standing supply | An agreed product list and forecast, replenished on a fixed cycle. | Regular, predictable consumption — chemotherapy protocols, dialysis support. |
| Tender supply | We respond to your published procurement tender with full regulatory documentation. | Government hospitals and formal procurement processes. |
| Special-access enquiry | Regulatory pathway assessment for an exceptional clinical need. Any import or supply depends on specific written DDA permission and applicable institutional documentation. | Rare indications or specialist therapies not registered or routinely stocked in Nepal. |
Institutional enquiry
Tell us what you need.
For procurement, pharmacy and clinical departments. We will come back to you within two working days.
Reporting an adverse event or product complaint? Use the pharmacovigilance route instead — it is monitored separately.
Discuss institutional supply
Tell us your requirement and we will confirm what we can supply and on what terms.